Jaundice after allogeneic hematopoietic
β
Manuel Mendizabal; Terina Chen; K. Rajender Reddy
π
Article
π
2009
π
John Wiley and Sons
π
English
β 297 KB
A 43-year-old man with acute lymphoblastic leukemia was treated with three cycles of hyper-CVAD (hyper fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone) followed by allogeneic hematopoietic stem cell transplantation (HCT) from a sibling. Six months later, the patient presen